Cargando…

Difference in the effects of switching from Candesartan to Olmesartan or Telmisartan to Olmesartan in hypertensive patients with type 2 diabetes: the COTO study

PURPOSE: This open-label controlled study compared the therapeutic efficacy of three representative angiotensin II receptor blockers (ARBs) in hypertensive patients with type 2 diabetes attending a hospital outpatient clinic. The primary measure in this study was morning home blood pressure (BP). PA...

Descripción completa

Detalles Bibliográficos
Autores principales: Daikuhara, Hiroyuki, Fukunaga, Kensaku, Ohshima, Tomie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3933665/
https://www.ncbi.nlm.nih.gov/pubmed/24600204
http://dx.doi.org/10.2147/DDDT.S53253